Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Daisy Alapat

Concepts (243)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
27
2024
3035
1.820
 Why?
Flow Cytometry
5
2018
546
0.910
 Why?
Immunoglobulins
2
2018
89
0.740
 Why?
Immunoglobulin kappa-Chains
2
2016
31
0.670
 Why?
Bone Marrow
7
2022
411
0.610
 Why?
DNA, Neoplasm
1
2018
171
0.600
 Why?
Hematopoietic Stem Cell Transplantation
4
2024
573
0.590
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
106
0.560
 Why?
Immunoglobulin lambda-Chains
1
2015
18
0.540
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
70
0.530
 Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.520
 Why?
Receptors, Antigen, B-Cell
1
2015
9
0.520
 Why?
Plasma Cells
2
2016
238
0.490
 Why?
Neoplasm, Residual
5
2022
166
0.470
 Why?
Plasmacytoma
3
2022
47
0.420
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
13
0.420
 Why?
Lymphoma, Mantle-Cell
1
2012
22
0.410
 Why?
Cell Differentiation
1
2015
720
0.410
 Why?
Carcinoembryonic Antigen
1
2011
15
0.390
 Why?
Calcitonin
1
2011
38
0.390
 Why?
Antigens, CD
1
2012
242
0.380
 Why?
Humans
44
2024
54284
0.360
 Why?
Carcinoma
1
2011
153
0.350
 Why?
Myogenin
1
2008
6
0.340
 Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.340
 Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.340
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2022
108
0.330
 Why?
Paraproteinemias
2
2022
80
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1056
0.290
 Why?
Neoplasms, Second Primary
2
2019
77
0.290
 Why?
Tumor Microenvironment
3
2023
209
0.280
 Why?
Middle Aged
16
2021
13088
0.270
 Why?
Prognosis
7
2024
2118
0.260
 Why?
Gene Expression Profiling
3
2016
1138
0.260
 Why?
Pancytopenia
3
2016
40
0.250
 Why?
Treatment Outcome
10
2022
5604
0.250
 Why?
Gastrointestinal Neoplasms
1
2022
46
0.210
 Why?
Neoplasms, Plasma Cell
2
2020
39
0.210
 Why?
Embolization, Therapeutic
2
2021
98
0.200
 Why?
Thrombocytopenia
1
2022
99
0.200
 Why?
Cryosurgery
1
2021
38
0.200
 Why?
Chromosome Deletion
2
2023
150
0.200
 Why?
Transplantation, Autologous
4
2024
476
0.190
 Why?
Female
18
2021
28441
0.190
 Why?
Skin Neoplasms
2
2016
532
0.180
 Why?
Male
15
2021
27334
0.180
 Why?
Aged
14
2021
10054
0.180
 Why?
Combined Modality Therapy
1
2021
692
0.170
 Why?
Ploidies
1
2018
13
0.160
 Why?
Hematopoietic Stem Cells
1
2019
215
0.160
 Why?
Leukemia, Myeloid, Acute
1
2019
191
0.160
 Why?
Herpesvirus 8, Human
1
2019
90
0.160
 Why?
Sarcoma, Myeloid
1
2017
22
0.150
 Why?
Chromosomes, Human, Pair 17
1
2017
43
0.150
 Why?
Kidney Diseases
1
2020
293
0.150
 Why?
Immunohistochemistry
3
2016
1089
0.150
 Why?
Lymph Nodes
2
2019
284
0.150
 Why?
Amyloidosis
2
2016
85
0.150
 Why?
CA-125 Antigen
1
2016
20
0.140
 Why?
Cell Cycle
1
2018
275
0.140
 Why?
Skin Diseases, Infectious
1
2016
7
0.140
 Why?
Leukemia, Promyelocytic, Acute
1
2016
10
0.140
 Why?
Anemia, Aplastic
1
2016
12
0.140
 Why?
Myeloproliferative Disorders
1
2016
28
0.140
 Why?
Electrophoresis, Capillary
1
2015
16
0.130
 Why?
In Situ Hybridization
1
2015
82
0.130
 Why?
Tumor Suppressor Protein p53
1
2017
250
0.130
 Why?
V(D)J Recombination
1
2015
4
0.130
 Why?
Immunophenotyping
1
2015
117
0.130
 Why?
Fatal Outcome
1
2015
225
0.130
 Why?
RNA, Messenger
2
2015
1202
0.130
 Why?
Diagnosis, Differential
3
2016
1136
0.130
 Why?
Bone Marrow Transplantation
2
2022
149
0.120
 Why?
Immunoglobulin Light Chains
1
2015
101
0.120
 Why?
Prealbumin
1
2014
24
0.120
 Why?
Bone Marrow Neoplasms
1
2014
15
0.120
 Why?
Neoplasm Proteins
1
2016
359
0.120
 Why?
Hodgkin Disease
1
2014
51
0.120
 Why?
Parvoviridae Infections
1
2013
20
0.110
 Why?
Parvovirus B19, Human
1
2013
17
0.110
 Why?
Polymerase Chain Reaction
1
2015
531
0.110
 Why?
Partial Thromboplastin Time
1
2012
12
0.110
 Why?
Prothrombin Time
1
2012
19
0.110
 Why?
Immunoglobulins, Intravenous
1
2013
55
0.110
 Why?
Afibrinogenemia
1
2012
5
0.110
 Why?
Cardiomyopathies
1
2014
129
0.110
 Why?
Retroperitoneal Neoplasms
1
2012
17
0.110
 Why?
Glycoproteins
1
2012
132
0.110
 Why?
Plasma Exchange
1
2012
33
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2012
9
0.110
 Why?
Predictive Value of Tests
1
2015
1048
0.110
 Why?
Phenotype
1
2015
820
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2016
866
0.100
 Why?
Histoplasma
1
2011
29
0.100
 Why?
Antigens, Fungal
1
2011
31
0.100
 Why?
Immunoenzyme Techniques
1
2011
165
0.100
 Why?
Hepatitis C
1
2012
94
0.100
 Why?
Histoplasmosis
1
2011
53
0.100
 Why?
Carcinoma, Neuroendocrine
1
2011
27
0.100
 Why?
In Situ Hybridization, Fluorescence
3
2023
278
0.100
 Why?
Adult
7
2021
14207
0.090
 Why?
Splenic Neoplasms
1
2009
2
0.090
 Why?
Dose-Response Relationship, Drug
2
2016
1476
0.090
 Why?
Disease Progression
3
2022
913
0.090
 Why?
Myelodysplastic Syndromes
1
2009
79
0.090
 Why?
Gene Expression
1
2012
664
0.090
 Why?
Retrospective Studies
4
2024
6432
0.080
 Why?
Mutagenesis, Site-Directed
1
2008
117
0.080
 Why?
Thyroid Neoplasms
1
2011
162
0.080
 Why?
Hemangioma
1
2009
83
0.080
 Why?
HIV Infections
1
2012
394
0.080
 Why?
Aged, 80 and over
4
2019
3431
0.080
 Why?
Survival Analysis
2
2021
735
0.080
 Why?
Protein Processing, Post-Translational
1
2008
183
0.080
 Why?
Stem Cell Transplantation
2
2022
196
0.070
 Why?
Cells, Cultured
2
2008
1737
0.070
 Why?
Graft vs Host Disease
1
2007
83
0.070
 Why?
Positron-Emission Tomography
2
2021
322
0.070
 Why?
Muscle Proteins
1
2008
307
0.070
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
39
0.070
 Why?
Semaphorin-3A
1
2004
2
0.060
 Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
 Why?
p38 Mitogen-Activated Protein Kinases
1
2005
99
0.060
 Why?
Nerve Degeneration
1
2004
33
0.060
 Why?
Mitogen-Activated Protein Kinase 3
1
2004
55
0.060
 Why?
Mitogen-Activated Protein Kinase 1
1
2004
55
0.060
 Why?
Muscle, Smooth, Vascular
1
2005
140
0.060
 Why?
Ferritins
1
2024
31
0.060
 Why?
Imidazoles
1
2005
142
0.060
 Why?
Antineoplastic Agents
1
2013
1300
0.060
 Why?
Myeloid Progenitor Cells
1
2023
19
0.060
 Why?
Pyridines
1
2005
137
0.060
 Why?
Pyrimidines
1
2005
196
0.060
 Why?
Gene Expression Regulation
1
2008
1062
0.060
 Why?
Adrenal Cortex Hormones
1
2023
95
0.060
 Why?
Hippocampus
1
2004
242
0.050
 Why?
Chromosomes, Human, Pair 1
1
2023
113
0.050
 Why?
Enzyme Inhibitors
1
2005
446
0.050
 Why?
Case-Control Studies
2
2019
1228
0.050
 Why?
Cohort Studies
2
2020
1543
0.050
 Why?
Mediastinum
1
2021
27
0.050
 Why?
Dexamethasone
1
2024
435
0.050
 Why?
Chromosome Aberrations
1
2023
316
0.050
 Why?
Axilla
1
2021
101
0.050
 Why?
Fever
1
2022
129
0.050
 Why?
Vincristine
1
2021
98
0.050
 Why?
Prednisone
1
2021
111
0.050
 Why?
Pelvis
1
2021
76
0.050
 Why?
Gastrointestinal Tract
1
2022
135
0.050
 Why?
T-Lymphocytes
1
2023
373
0.050
 Why?
Neurons
1
2004
486
0.050
 Why?
Cyclophosphamide
1
2021
172
0.050
 Why?
Signal Transduction
2
2004
1753
0.050
 Why?
Fluorodeoxyglucose F18
1
2021
205
0.050
 Why?
Radiopharmaceuticals
1
2021
238
0.050
 Why?
Tumor Burden
1
2020
142
0.050
 Why?
Alzheimer Disease
1
2004
367
0.050
 Why?
Time Factors
2
2017
3213
0.050
 Why?
Doxorubicin
1
2021
259
0.040
 Why?
False Negative Reactions
1
2019
36
0.040
 Why?
Herpesvirus 4, Human
1
2019
38
0.040
 Why?
Epstein-Barr Virus Infections
1
2019
34
0.040
 Why?
Registries
1
2022
553
0.040
 Why?
Herpesviridae Infections
1
2019
46
0.040
 Why?
Mice
3
2023
6413
0.040
 Why?
Cell Line, Tumor
1
2023
1550
0.040
 Why?
Adolescent
1
2011
6897
0.040
 Why?
Virus Diseases
1
2019
44
0.040
 Why?
Phosphorylation
3
2005
614
0.040
 Why?
Antibodies, Monoclonal
1
2023
562
0.040
 Why?
Genome, Viral
1
2019
100
0.040
 Why?
DNA, Viral
1
2019
142
0.040
 Why?
Follow-Up Studies
1
2024
2387
0.040
 Why?
Tomography, X-Ray Computed
2
2014
1213
0.040
 Why?
Neoplasm Recurrence, Local
1
2022
644
0.040
 Why?
Scleromyxedema
1
2016
5
0.040
 Why?
Schnitzler Syndrome
1
2016
4
0.040
 Why?
Xanthomatosis
1
2016
9
0.040
 Why?
Cryoglobulinemia
1
2016
12
0.040
 Why?
Asymptomatic Diseases
1
2016
43
0.030
 Why?
Liver
1
2022
1225
0.030
 Why?
POEMS Syndrome
1
2016
32
0.030
 Why?
Melphalan
1
2016
180
0.030
 Why?
Disease-Free Survival
1
2016
485
0.030
 Why?
Reed-Sternberg Cells
1
2014
2
0.030
 Why?
HIV Seronegativity
1
2014
3
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
206
0.030
 Why?
Karyotype
1
2014
19
0.030
 Why?
Animals
3
2023
14385
0.030
 Why?
Fusion Proteins, bcr-abl
1
2014
23
0.030
 Why?
Thalidomide
1
2016
397
0.030
 Why?
Heterozygote
1
2014
96
0.030
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
48
0.030
 Why?
Cell Division
2
2005
330
0.030
 Why?
Remission Induction
1
2014
221
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
673
0.030
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
474
0.030
 Why?
Fibrinogen
1
2012
37
0.030
 Why?
Mutation
1
2019
1501
0.030
 Why?
Blood Coagulation
1
2012
69
0.030
 Why?
Survival Rate
1
2015
951
0.030
 Why?
Neoplasm Staging
1
2015
806
0.030
 Why?
Reference Values
1
2012
354
0.030
 Why?
Risk Assessment
1
2017
1361
0.030
 Why?
Antibodies, Fungal
1
2011
4
0.030
 Why?
Mycological Typing Techniques
1
2011
3
0.030
 Why?
Cross Reactions
1
2011
56
0.030
 Why?
Lung Diseases, Fungal
1
2011
31
0.030
 Why?
Biopsy
1
2014
692
0.030
 Why?
Immunocompromised Host
1
2011
130
0.020
 Why?
Splenectomy
1
2009
35
0.020
 Why?
Severity of Illness Index
1
2012
1084
0.020
 Why?
Sensitivity and Specificity
1
2011
923
0.020
 Why?
Blood Transfusion
1
2009
138
0.020
 Why?
Transplantation, Isogeneic
1
2007
2
0.020
 Why?
Mice, Inbred C3H
1
2007
82
0.020
 Why?
Laparoscopy
1
2009
188
0.020
 Why?
Cyclosporine
1
2007
66
0.020
 Why?
Mice, SCID
1
2007
196
0.020
 Why?
Models, Animal
1
2007
255
0.020
 Why?
Magnetic Resonance Imaging
1
2014
1604
0.020
 Why?
Immunosuppressive Agents
1
2007
248
0.020
 Why?
Macromolecular Substances
1
2004
47
0.020
 Why?
Physical Chromosome Mapping
1
2004
9
0.020
 Why?
tau Proteins
1
2004
30
0.020
 Why?
Genetic Complementation Test
1
2004
55
0.020
 Why?
Epidermal Growth Factor
1
2004
38
0.020
 Why?
Cricetulus
1
2004
102
0.020
 Why?
Catalytic Domain
1
2004
62
0.020
 Why?
Epitopes
1
2004
89
0.020
 Why?
Microtubule-Associated Proteins
1
2004
78
0.020
 Why?
Cloning, Molecular
1
2004
198
0.020
 Why?
Mutagenesis
1
2004
77
0.020
 Why?
Cricetinae
1
2004
209
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
122
0.020
 Why?
Receptors, Cell Surface
1
2004
130
0.010
 Why?
RNA
1
2004
202
0.010
 Why?
Cell Survival
1
2005
657
0.010
 Why?
Nerve Tissue Proteins
1
2004
199
0.010
 Why?
Amino Acid Sequence
1
2004
767
0.010
 Why?
Molecular Sequence Data
1
2004
980
0.010
 Why?
Mice, Inbred C57BL
1
2007
1999
0.010
 Why?
Cell Line
1
2004
1153
0.010
 Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (243) concept(s)
_
Co-Authors Expand Description
See all (41) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department